Skip to main content

Recurrence

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
1 program
1
VareniclinePhase 41 trial
Active Trials
NCT00944554Completed104Est. May 2011
Erbe
ErbeGermany - Tübingen
1 program
Argon Plasma CoagulationN/A1 trial
Active Trials
NCT03654209Completed384Est. Dec 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PfizerVarenicline
ErbeArgon Plasma Coagulation

Clinical Trials (2)

Total enrollment: 488 patients across 2 trials

Relapse Prevention With Varenicline

Start: Oct 2008Est. completion: May 2011104 patients
Phase 4Completed
NCT03654209ErbeArgon Plasma Coagulation

Post-resection Treatment of Large Colon Polyps

Start: Oct 2018Est. completion: Dec 2022384 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.